CytoDel Overview
Latest Deal Type
Accelerator/Inc
CytoDel General Information
Description
Provider of a biotechnology platform intended to produce recombinant derivatives of botulinum neurotoxin. The company's platform manipulates the BONT molecule into a drug delivery vehicle that can deliver therapeutic molecules to the inside of neurons with important implications, enabling medical researchers to develop drugs and facilitate the treatment of nervous system disorders, chronic pain and neuro-degenerative diseases.
CytoDel Timeline
Want to dig into this profile?
We’ll help you find what you need
Learn more
CytoDel Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 5. Accelerator/Incubator |
|
|
00.00 |
|
Completed |
Startup |
| 4. Later Stage VC (Series A) |
16-Jan-2018 |
00.00 |
00.00 |
000.00 |
Completed |
Startup |
| 3. Grant |
01-Jul-2017 |
000.00 |
|
|
Completed |
Startup |
| 2. Grant |
01-Jan-2014 |
$224K |
|
|
Completed |
Startup |
| 1. Accelerator/Incubator |
13-Dec-2013 |
|
|
|
Completed |
Startup |
CytoDel Cap Table
To view CytoDel‘s complete cap table, request access >>
| Stock |
# of Shares
Authorized |
Par Value |
Dividend Rate (%) |
Original
Issue Price |
Liquidation |
Liquidation
Pref. Multiple |
Conversion Price |
% Owned |
| Series A-1 |
0,000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
00.00 |
| Series A-2 |
000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
00 |
CytoDel Competitors (4)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| Amgen |
Formerly PE-Backed |
Thousand Oaks, CA |
00000 |
00.000 |
000000000000 |
00.000 |
| 000000 |
Formerly VC-backed |
Cambridge, MA |
0000 |
000.00 |
00000000000 |
000.00 |
| 000 00000 |
Corporation |
Indianapolis, IN |
00000 |
|
000000 - 000 |
|
| 0000 000000 |
Corporation |
Frankfurt, Germany |
0000 |
|
|
|
CytoDel Executive Team (3)
| Name |
Title |
Board Seat |
Contact Info |
| Konstantin Ichtchenko Ph.D |
Co-Founder and Chief Strategy Officer |
|
|
| Philip Band Ph.D |
Co-Founder, Co-Inventor, Chief Executive Officer & Board Member |
|
|
1 Former Executive
CytoDel Board Members (4)
| Name |
Representing |
Role |
Since |
| André Gudger |
CytoDel |
Board Member |
000 0000
|
| Lawrence Remmel JD |
Self |
Board Member |
000 0000
|
| Margery Fischbein |
Self |
Board Member |
000 0000
|
| Philip Band Ph.D |
CytoDel |
Co-Founder, Co-Inventor, Chief Executive Officer & Board Member |
000 0000
|